Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Virtual Reality Exercise Intradialysis: Tolerance and Dialysis Dose Effects During the Last vs. First Part of the Hemodialysis Session

NCT04046042 is registered in ClinicalTrials.gov with Cardenal Herrera University as lead sponsor.

NCT NCT04046042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04046042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Virtual Reality Exercise Intradialysis: Tolerance and Dialysis Dose Effects During the Last vs. First Part of the Hemodialysis Session
Lead sponsor
Cardenal Herrera University
Phase
Not applicable
Overall status
Unknown status
Start date
September 2, 2019
Completion date
August 30, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease on dialysis, hemodialysis complication